Study Stopped
COVID
Effect of WhatsApp Messenger on Uptake of CRC Screening Study
The Effectiveness of WhatsApp Messenger on the Uptake of Colorectal Cancer Screening: a Non-inferiority Randomized Controlled Study
1 other identifier
interventional
N/A
1 country
1
Brief Summary
It is estimated that there are about 1.4 million patients with colorectal cancer (CRC) worldwide, with a rising trend in CRC incidence in many Asian Pacific countries1. In Hong Kong, colorectal cancer ranks first in cancer incidence and second in cancer mortality based on data from 20142. Recent guidelines from USA, Europe and Asia Pacific region recommend CRC screening for average-risk asymptomatic individuals starting at age 503-5. Modalities such as guaiac-based fecal occult blood tests (gFOBT), fecal immunochemical tests (FIT), flexible sigmoidoscopy (FS), and colonoscopy are among the acceptable options for CRC screening3-5. Department of Health of Hong Kong launched a Colorectal Cancer Screening Pilot Program in late 2016. This is a subsidized program offering primary care consultation with FIT. For those subjects with FIT positive, colonoscopy specialist consultation and colonoscopy will be arranged. The local uptake rate of CRC screening was reported to be 24.5%8 , which is relatively low when compared to other developed county9. In recent years, social media (SM) has become an increasingly popular source of health information10. By providing an easily accessible and interactive channel of communication between reviewers and information providers, it has potential values for affecting public health. However, the effects of SM on uptake of CRC screening has not yet been studied. WhatsApp Messenger, is the most popular social media messaging app worldwide. This randomized controlled study will investigate the effect of WhatsApp vs telephone intervention on the uptake of CRC screening.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 6, 2017
CompletedFirst Posted
Study publicly available on registry
November 9, 2017
CompletedStudy Start
First participant enrolled
February 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedAugust 5, 2021
August 1, 2021
10 months
November 6, 2017
August 2, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
CRC screening uptake rate
Number of subjects participating in CRC screening after study intervention divided by the total number of subjects in each study arm
1 year
Study Arms (2)
WhatsApp message
ACTIVE COMPARATORWhatsApp messages will be sent to invite subjects to participate CRC screening
Telephone call
ACTIVE COMPARATORTelephone call will be made to invite subjects to participate CRC screening
Interventions
WhatsApp message will be sent to invite subjects to participate in CRC screening
Telephone call will be made to invite subjects to participate in CRC screening
Eligibility Criteria
You may qualify if:
- Age between 50 - 70
- Asymptomatic
You may not qualify if:
- Lack of access to WhatsApp messenger
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Prince of Wales Hospital
Hong Kong, Hong Kong
Study Officials
- PRINCIPAL INVESTIGATOR
Yuen Tung Thomas Lam, MSc
Chinese University of Hong Kong
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Nursing Officer
Study Record Dates
First Submitted
November 6, 2017
First Posted
November 9, 2017
Study Start
February 1, 2019
Primary Completion
December 1, 2019
Study Completion
December 31, 2019
Last Updated
August 5, 2021
Record last verified: 2021-08